Mark McGirney

Retired at Iroko Pharmaceuticals, LLC - Philadelphia, Pennsylvania, US

Mark McGirney's Colleagues at Iroko Pharmaceuticals, LLC
Mary Narus

Professional Sales Representative

Contact Mary Narus

Megan Bishop

Pharmaceutical Sales Specialist

Contact Megan Bishop

Cullen Haworth

Territory Business Manager

Contact Cullen Haworth

Scott Stanley

Regional Business Manager

Contact Scott Stanley

View All Mark McGirney's Colleagues
Mark McGirney's Contact Details
HQ
(267) 546-1480
Location
Company
Iroko Pharmaceuticals, LLC
Mark McGirney's Company Details
Iroko Pharmaceuticals, LLC logo, Iroko Pharmaceuticals, LLC contact details

Iroko Pharmaceuticals, LLC

Philadelphia, Pennsylvania, US • 100 - 249 Employees
Major Drugs

Iroko is dedicated to advancing the science of analgesia. Iroko Pharmaceuticals is named for the majestic West African iroko tree. Its deep roots represent strength and stability, while its leaves symbolize renewal and innovation. At Iroko, we believe it is possible to offer new options for responsible pain management. Medical and regulatory organizations have recommended the use of the lowest effective doses of NSAIDs for the shortest duration of time. We are using innovative proprietary SoluMatrix Fine Particle Technology™ to develop new drug products based on existing NSAIDs to relieve pain at lower doses. To learn more, please visit our Corporate Website.

Iroko News Medical Iroko Pharma
Details about Iroko Pharmaceuticals, LLC
Frequently Asked Questions about Mark McGirney
Mark McGirney currently works for Iroko Pharmaceuticals, LLC.
Mark McGirney's role at Iroko Pharmaceuticals, LLC is Retired.
Mark McGirney's email address is ***@iroko.com. To view Mark McGirney's full email address, please signup to ConnectPlex.
Mark McGirney works in the Major Drugs industry.
Mark McGirney's colleagues at Iroko Pharmaceuticals, LLC are Mary Narus, Megan Bishop, Terri Ledva, Mia Mclemore, Cullen Haworth, Scott Stanley, Michael Moser and others.
Mark McGirney's phone number is (267) 546-1480
See more information about Mark McGirney